Proteome Sciences (LON:PRM) Shares Down 11% – Should You Sell?

Proteome Sciences plc (LON:PRM)’s share price dropped 11% during trading on Thursday . The stock traded as low as GBX 2.80 ($0.04) and last traded at GBX 3.16 ($0.04). Approximately 815,721 shares were traded during trading, an increase of 280% from the average daily volume of 214,483 shares. The stock had previously closed at GBX 3.55 ($0.05).

Proteome Sciences Price Performance

The firm has a market capitalization of £9.98 million, a price-to-earnings ratio of -2.45 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66. The stock’s 50 day moving average price is GBX 4.05 and its two-hundred day moving average price is GBX 3.46.

Proteome Sciences (LON:PRM) last issued its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.02)) earnings per share for the quarter. Proteome Sciences had a negative return on equity of 0.01% and a negative net margin of 0.04%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.